VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
VIRX
Delisted
VIRX was delisted on the 3rd of February, 2025.
40 hedge funds and large institutions have $4.91M invested in Viracta Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
49% less capital invested
Capital invested by funds: $9.58M → $4.91M (-$4.67M)
Holders
40
Holding in Top 10
1
Calls
$6K
Puts
–
Top Buyers
| 1 | +$24.3K | |
| 2 | +$14.3K | |
| 3 | +$13K | |
| 4 |
Renaissance Technologies
New York
|
+$12K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$2.97K |
Top Sellers
| 1 | -$266K | |
| 2 | -$35.5K | |
| 3 | -$25.7K | |
| 4 |
BlackRock
New York
|
-$24.2K |
| 5 |
LCM
Laurion Capital Management
New York
|
-$10.4K |